Biden’s BIG PHARMA, BIG TECH-Aligned FDA Nominee Robert Califf Faces Criticism For Consulting Past

The Revolving Door Project’s Jeff Hauser details the potential conflict-of-interest issue with the Biden administration’s nomination to head the FDA.